Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New Home-Based program aims to help lung cancer survivors and partners get fit and reduce stress

NCT ID NCT07214441

First seen Oct 31, 2025 · Last updated Jun 20, 2026 · Updated 35 times

Summary

This study tests a 12-week program called Breathe Easier+ for people who have finished treatment for non-small cell lung cancer and their partners. The program includes guided walking, resistance training, coaching calls, and meditation delivered via smartphone or tablet. Researchers want to see if it is feasible and if it helps improve fitness, reduce symptoms like fatigue and breathlessness, and lower stress.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CANCER (NON-SMALL CELL) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • University of South Carolina

    Columbia, South Carolina, 29208, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Breathe Easier+ (BE+) behavioral intervention including walking, resistance training, coaching, and meditation

What this could lead to

If successful, this program could offer a practical way for lung cancer survivors and their partners to improve physical fitness and manage symptoms like fatigue and stress from home.

What could go wrong

This is a very small, early feasibility study with only 20 participants and no comparison group, so results may not apply broadly. The program requires significant commitment and technology access.

Conditions

The condition(s) this trial relates to.

Motor Activity non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.